Comprehensive review of fetal adenocarcinoma of the lung

Código QR

Comprehensive review of fetal adenocarcinoma of the lung

Luisa María Ricaurte,1 Oscar Arrieta,2 Zyanya Lucia Zatarain-Barrón,2 Andrés F Cardona1,3 1Foundation for Clinical and Applied Cancer Research – FICMAC, Bogotá, Colombia; 2Thoracic Oncology Unit, National Cancer Institute (INCan), Méxi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	lung cancer fetal adenocarcinoma outcomes chemotherapy radiotherapy. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b1a5568e4fe842a1a2d5656d0acb2fad
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
por: Elena V. Reutova, et al.
Publicado: (2021)

Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study
por: Minami S, et al.
Publicado: (2017)

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
por: Qunhao Zheng, et al.
Publicado: (2021)

Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
por: Guangchuan Deng, et al.
Publicado: (2021)

AGTR1 Inhibits the Progression of Lung Adenocarcinoma
por: Xiong L, et al.
Publicado: (2021)

Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression
por: Liu Z, et al.
Publicado: (2021)

An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma
por: Ning Zhou, et al.
Publicado: (2021)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shijie Shang, et al.
Publicado: (2021)

Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
por: Huan Zhang, et al.
Publicado: (2021)

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”
por: Umberto Caterino, et al.
Publicado: (2021)

Development and Validation of a Radiomics Nomogram for Differentiating Pulmonary Cryptococcosis and Lung Adenocarcinoma in Solitary Pulmonary Solid Nodule
por: Jiabi Zhao, et al.
Publicado: (2021)

The Earliest Stage of Lung Adenocarcinoma:  the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
por: Huikang XIE, et al.
Publicado: (2021)

INFLUENCE OF INGARON UPON IMMUNE STATE OF THE PATIENTS WITH ADENOCARCINOMA OF LUNG IN THE COURSE OF ADJUVANT THERAPY
por: S. P. Pyltsin, et al.
Publicado: (2015)

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: David L. Billing, et al.
Publicado: (2021)

How Does the Gradient Measure of the Lung SBRT Treatment Plan Depend on the Tumor Volume and Shape?
por: Yanhua Duan, et al.
Publicado: (2021)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Jiahui Han, et al.
Publicado: (2021)

The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine
por: Yanli Xiong, et al.
Publicado: (2021)

Preoperative CT-Based Radiomics Combined With Nodule Type to Predict the Micropapillary Pattern in Lung Adenocarcinoma of Size 2 cm or Less: A Multicenter Study
por: Meirong Li, et al.
Publicado: (2021)

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Eleni Gkika, et al.
Publicado: (2021)

Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer
por: Minami S, et al.
Publicado: (2016)

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ning-Yi Ma, et al.
Publicado: (2021)

Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure
por: Shun-Dong Dai, et al.
Publicado: (2021)

Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique
por: Yangchun Gu, et al.
Publicado: (2021)

Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Maja Šutić, et al.
Publicado: (2021)

Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
por: Moonkyoo Kong, et al.
Publicado: (2021)

Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer
por: Hao Yu, et al.
Publicado: (2021)

Research Progress in CircRNA and Radiotherapy Resistance of Non-small Cell Lung Cancer
por: Weilong LI, et al.
Publicado: (2021)

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Min Kyu Kang, et al.
Publicado: (2021)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
por: Minmin Li, et al.
Publicado: (2021)

GDPLichi: a DNA Damage Repair-Related Gene Classifier for Predicting Lung Adenocarcinoma Immune Checkpoint Inhibitors Response
por: Yang Leng, et al.
Publicado: (2021)

Adenocarcinoma lung presenting with meningeal carcinomatosis
por: Ramakant Dixit, et al.
Publicado: (2021)

Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature
por: Huanhuan Xu, et al.
Publicado: (2021)

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
por: Yu Chen, et al.
Publicado: (2021)

Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
por: Natalja Eigeliene, et al.
Publicado: (2021)

Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancer
por: Aridgides P, et al.
Publicado: (2018)

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
por: Rossi G, et al.
Publicado: (2017)

Long non-coding RNA LINC01559 exerts oncogenic role via enhancing autophagy in lung adenocarcinoma
por: Zhuochen Zhao, et al.
Publicado: (2021)

Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
por: Elissa J Zhang, et al.
Publicado: (2021)

Overexpression of 15-Hydroxyprostaglandin Dehydrogenase Inhibits A549 Lung Adenocarcinoma Cell Growth via Inducing Cell Cycle Arrest and Inhibiting Epithelial-Mesenchymal Transition
por: Wang W, et al.
Publicado: (2021)

Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report
por: Shuluan Li, et al.
Publicado: (2021)